Winstro ®

What Is Stanozolol Injection 100mg?

Winstro by Sigma Pharmaceuticals is a stanozolol injection 100mg per mL. Stanozolol is a derivative of dihydrotestosterone (DHT) with a pyrazole ring fused to its structure, which gives it a distinctive profile among anabolic compounds. It is one of the few compounds in its class that has been produced as both an oral tablet and an injectable preparation.

Medical Use and History

Stanozolol was introduced in 1962. In the United States it was prescribed for hereditary angioedema, where it helps prevent swelling attacks, and it has also been used for anemia and certain circulatory conditions. Injectable forms were used in human and veterinary medicine. Oral stanozolol for hereditary angioedema was discontinued in the United States in 2010.

Key Properties of Stanozolol Injection 100mg

• Does not convert to estrogen (non-aromatizing)
• Anabolic activity with relatively low androgenic effects
• Increases production of C1-esterase inhibitor, the basis of its angioedema use

Every vial of stanozolol injection 100mg from Sigma carries a single-use security code.

Stanozolol is a Schedule III controlled substance in the United States. The information on this page is provided for reference only.